Noor is the CEO and co-founder of Matrisome Bio. As founding CEO, she raised the company’s seed round and defined its strategic vision. With over 15 years of expertise in oncology and ECM biology, she is an inventor of the company’s core technology. She holds a PhD in immunology, postdoctoral training at MIT’s Hynes Lab and was named a 2025 Termeer Fellow.

Monica is an accomplished oncology and immunology R&D leader. She has advanced multiple programs from target identification into the clinic, and brings expertise in discovery and development across modalities, including radioligand therapies. Before joining Matrisome Bio, Monica held senior roles at Egle and Jounce Therapeutics. She has a PhD in Molecular Genetics.

Tad is a experienced biopharma business and corporate development executive. He has played an integral strategic role in funding and scaling biotechnology companies from early research to clinical development and through commercial launch.  Prior to Matrisome Bio, Tad served in leadership roles with several companies, including Ribon Therapeutics, GRO Biosciences, Crescendo Biologics and Merrimack Pharmaceuticals.

Alice oversees the protein engineering platform at Matrisome Bio. She brings multidisciplinary expertise across modalities in oncology. She was a former research fellow in the David M. Livingston lab at Dana-Farber Cancer Institute and holds a PhD in Molecular Biology.

Dennis oversees the non-dilutive funding efforts at Matrisome Bio and supports protein engineering and biophysical characterization. Dennis is an experienced protein biochemist and former group leader at MIT’s Koch Institute for Cancer Research. He holds a PhD in Cell Biology from LMU in Munich and received his postdoctoral training from the University of Chicago.

Suma oversees all in vivo preclinical work at Matrisome Bio. She brings expertise in radioligand therapeutics, preclinical pharmacology , and molecular imaging. Suma’s previous experience includes roles at Harvard MGH, Fusion Pharmaceuticals, and UIUC.

Devyn supports Matrisome Bio’s protein engineering platform. She has expertise in molecular biology, and synthetic biology, including hands-on experience with assay development and laboratory automation. She holds a BS in Biology.